COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 14:30, il y a 8 mois 17 jours Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy Wellgistics Health terminates equity purchase agreement with Hudson Global Ventures, LLC to focus on long-term shareholder value. Strategic shift towards accretive financing and growth opportunities Shareholder Value Termination Equity Purchase Agreement Wellgistics Health Accretive Financing
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 14:30, il y a 8 mois 17 jours Sekur Private Data Ltd. Receives Auditor Approval to Accept Crypto Currencies as Payment Form for Sekur Swiss Hosted Privacy Communications Solutions Sekur Private Data Ltd. receives approval from auditors to accept cryptocurrency as payment for Swiss-hosted privacy communications solutions, amid rising cyber threats targeting the crypto community Cybersecurity Solutions Cryptocurrency Payment Sekur Private Data Ltd. Swiss-hosted Privacy Communications Crypto Community
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 14:23, il y a 8 mois 17 jours Amundi Physical Metals plc: Final Terms Amundi Physical Metals plc issues 850,500 ETC Securities of Amundi Physical Gold ETC under its Secured Precious Metal Linked ETC Securities Programme. Final terms include metal entitlement and listing details Listing Amundi Physical Metals Plc ETC Securities Precious Metal Final Terms
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 14:22, il y a 8 mois 17 jours Original-Research: Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates recommendation on Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG to BUY with €1.50 target price. Detailed analysis on 2024 results and 2025 outlook First Berlin Equity Research Buy Recommendation Financial Analysis 2024 Results Deutsche Effecten
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 14:19, il y a 8 mois 17 jours Amundi Physical Metals plc: UK Final Terms Amundi Physical Metals plc issues 850,500 ETC Securities of Amundi Physical Gold ETC under its Secured Precious Metal Linked ETC Securities Programme. Tranche 737's final terms are defined in this document Amundi Physical Metals Plc ETC Securities Precious Metal Final Terms Tranche 737
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 14:15, il y a 8 mois 17 jours Inspire Veterinary Partners Reports Second Quarter 2025 Financial Results Inspire Veterinary Partners reports 5.7% increase in clinic revenues and 10% decrease in net losses for Q2 2025, along with new acquisitions and financial highlights Financial Results Inspire Veterinary Partners Net Losses Q2 2025 Clinic Revenues
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 14:15, il y a 8 mois 17 jours Vision Marine Positions for Growth with Exclusive Nimbus Boats USA Distribution on Florida's West Coast Vision Marine partners with Nimbus Boats USA to exclusively distribute premium Scandinavian-designed powerboats on Florida's West Coast, enhancing choices for boaters and expanding market reach Vision Marine Florida Market Exclusive Distribution Nimbus Boats USA Scandinavian Design
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 14:00, il y a 8 mois 17 jours urban-gro, Inc. Enters into Non-Binding Letter of Intent for Sale of 2WR Subsidiary urban-gro, Inc. announces non-binding letter of intent with CM Capital Management for sale of 2WR architectural design subsidiary's assets. Transaction subject to negotiation and due diligence Asset Sale Letter Of Intent Urban-gro Inc. Architectural Design CM Capital Management
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 14:00, il y a 8 mois 17 jours Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue Jaguar Health, Inc. reports 35% revenue increase in Q2 2025 for prescription & non-prescription products, including license revenue. Mytesi prescription volume up 6.5%. Crofelemer trial yields positive results Jaguar Health Inc. FDA Meeting Crofelemer Trial Q2 2025 Revenue Mytesi Prescription Volume
COMMUNIQUÉ DE PRESSE publié le 14/08/2025 à 14:00, il y a 8 mois 17 jours Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20 Aspire Biopharma to present patent-pending drug delivery tech at Sidoti Virtual Investor Conference on August 20. One-on-one meetings available for investors. Learn about disruptive technology Sidoti Virtual Investor Conference Drug Delivery Aspire Biopharma Patent-pending Disruptive Technology
Publié le 30/04/2026 à 21:21, il y a 14 heures 1 minute CP -Mise à disposition du rapport financier annuel 2025
Publié le 30/04/2026 à 20:00, il y a 15 heures 21 minutes AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Publié le 30/04/2026 à 20:00, il y a 15 heures 21 minutes AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Publié le 30/04/2026 à 19:16, il y a 16 heures 6 minutes AXA announces the results of its Shareholders' Meeting
Publié le 30/04/2026 à 19:16, il y a 16 heures 6 minutes AXA annonce les résultats de son Assemblée Générale
Publié le 01/05/2026 à 07:35, il y a 3 heures 47 minutes Snipp Interactive Reports Financial Results for Q4 and Fiscal 2025; Announces Conference Call on May 5, 2026
Publié le 01/05/2026 à 04:00, il y a 7 heures 22 minutes Jericho Energy Ventures Announces Short Delay in Filing of 2025 Annual Financial Statements
Publié le 01/05/2026 à 03:25, il y a 7 heures 57 minutes McEwen Inc. and Golden Lake Exploration Inc. Announce Closing of Arrangement
Publié le 01/05/2026 à 02:55, il y a 8 heures 27 minutes GLG Life Tech Corporation Reports 2025 Annual & Fourth Quarter Financial Results
Publié le 01/05/2026 à 01:00, il y a 10 heures 22 minutes PPX Mining Announces Grant of Stock Options, Restricted Share Units and Deferred Share Units
Publié le 01/05/2026 à 10:15, il y a 1 heure 7 minutes Custodian Property Income REIT plc: Total Voting Rights